24/06/2025
🚨 Medclair Technology Featured in French Pilot Study 🇫🇷
💡 A new presentation from Hospices Civils de Lyon, one of France’s largest hospital groups, highlights the urgent need to reduce healthcare staff exposure to Nitrous Oxide.
📍 At Hôpital Édouard Herriot in Lyon, our mobile unit was used in 12 out of 21 clinical sessions during a recent pilot study.
👉🏻 The goal? To measure staff exposure to N2O with and without destruction systems in place.
✅ Initial findings show that Medclair’s system can significantly reduce N2O concentrations in clinical environments—efficiently and without disrupting care.
📄 Read the study here (in French):
https://www.slideshare.net/slideshow/analgesie-par-meopa-reduire-les-niveaux-d-exposition-professionnelle-au-protoxyde-d-azote-n2o/280528194
Le mélange équimolaire d’oxygène et de protoxyde d’azote (MEOPA) est largement utilisé en milieu hospitalier pour l'analgésie de courte durée des actes douloureux (réduction de fractures, ponction, etc.). Les avantages du MEOPA sont nombreux : soulagement rapide de la douleur, rapidité d...